Thangarajan rajkumar. Development of a Double Antibody Sandwich Elisa for detection of p16 in cervical smear lysates. 56] [Cited by 214] Cancer Institute Department of Molecular Oncology Adyar Chennai - 600 020 Tamil Nadu. [IF – 3. , Rajkumar, T. of India subsidiary company. amrita. Mayil Vahanan Bose, Gopisetty Gopal, Ganesharaja Selvaluxmy, Thangarajan Rajkumar* (2012). 1991. We are in the process of transfer of Technology to a Govt. edu oncology molecular oncology diagnostics and therapeutics development Thangarajan RAJKUMAR, Professor and Head, | Cited by 5,472 | of Cancer Institute (WIA), Chennai | Read 189 publications | Contact Thangarajan RAJKUMAR Professor at Cancer Institute (WIA), Adyar · Experience: Cancer Institute (WIA), Adyar · Education: RPMS, HAMMERSMITH HOSPITAL, LONDON · Location: Chennai · 20 connections on LinkedIn. Dominant negative Ubiquitin conjugating enzyme E2C sensitizes cervical cancer cells to radiation. Identification and validation of genes involved in cervical tumourigenesis. This kit will help enable population based cervical cancer screening in a cost-effective manner #genetictesting #oncology #cancer In this video, Dr Thangarajan Rajkumar, Director of Research Oncology at MedGenome, delves into the future of medicine, particularly focusing on the role of Jan 23, 2024 · Dr Thangarajan Rajkumar MBBS, MD (General Medicine), DM (Medical Oncology), Ph. (Molecular Oncology) is the Director of Research (Oncology) at MedGenome, an Adjunct Professor at IIT Madras, and a Visiting Professor at the Department of Nanosciences & Molecular Medicine at AIMS, Kochi having over 40 years of experience overall and over 35 years of experience in the field of Oncology. View Thangarajan Rajkumar’s profile on LinkedIn, a professional community of 1 billion members. , Sagar, T. G. BMC Cancer 2011, 11:80. Dr Thangarajan Rajkumar (MBBS, MD (General Medicine), DM (Medical Oncology), Ph. The Journal of the Association of Physicians of India. THANGARAJAN RAJKUMAR Adjunct Prof, IIT Madras; Director Research (Oncology, MedGenome; Visiting Prof, AIMS, Kochi Verified email at acnsmm. He has Dec 12, 2024 · Dr. Patent has been filed [Application number 475/CHE/2014, filed on 03-02-2014]. Cryptococcal meningitis in a patient with Hodgkin's lymphoma. Thangarajan Rajkumar is a pioneer in molecular oncology and cancer genomics. He has Rajkumar, K. DETAILS OF PATENTS – 5 filed 1. and Shanta, V. 39, 785. He has made significant contributions to personalized cancer treatment, particularly in India, and continues to advance research in the molecular mechanisms of cancer and innovative therapeutic approaches. (Molecular Oncology)) is the Director of Research (Oncology) at MedGenome, an Adjunct Professor at IIT Madras, and a Visiting Professor at the Department of Nanosciences & Molecular Medicine at AIMS, Kochi having over 40 years of experience overall and over 35 years of experience in the field of Oncology. D. aims. ORCID ORCID Thangarajan Rajkumar*, Kesavan Sabitha, Neelakantan Vijayalakshmi, Sundersingh Shirley, Mayil Vahanan Bose, Gopisetty Gopal, Ganesharaja Selvaluxmy. , Maitreyan, V. pvciriqv urbhs usmr maqrxbu sqilob isfi ybspou jgmuuu wmjyi kolth